Glucosamine treats the underlying cause of osteoarthritis and the therapeutic effect can only be seen after 1 to 3 weeks. Therefore, it is advisable to take an analgesic or anti-inflammatory drug if required during the first 2 to 3 weeks of therapy with Glucosamine.
Administration during the first three months of pregnancy must be avoided.
Safety and effectiveness have not been established in children, therefore children should avoid using Glucosamine.
The administration in patients with severe hepatic or renal insufficiency should be made under medical supervision. A doctor should be consulted in order to exclude the presence of other joint conditions/diseases for which an alternative treatment should be considered.
This product contains Glucosamine derived from seafood, therefore should not be given to patients who are allergic to shellfish.
This product contains Chondroitin from bovine source.
No effects on the ability to drive or to operate machines are expected.
Powd for oral soln: Caution should be taken for people with diabetes, impaired liver or kidney functions.